High-Level Overview
Amiti Ventures is a U.S.-Israeli early-stage venture capital firm specializing in deep tech investments, targeting seed and Series A rounds in transformational technologies.[1][2][3] Led by partners like Ben Rabinowitz (Founder, CEO & CIO) and Yafit Schwartz (General Partner & COO), Amiti backs Israeli entrepreneurs building ambitious solutions in sectors such as semiconductors, cybersecurity, AI, big data, mobile, and computational biology, with a portfolio featuring successes like Innoviz (NASDAQ: INVZ), Valens (NYSE: VLN), and acquisitions including Corephotonics and Waze.[3][4] The firm has raised multiple funds, including the open Amiti IV ($110M) and Amiti III, emphasizing analytical, contrarian visions to scale startups from market fit to global leadership while providing hands-on strategic support.[1][2][3]
Amiti's investment philosophy centers on partnering with "deep-tech outliers" tackling foundational problems before markets fully recognize the opportunity, fostering Israel's tech ecosystem through founder-friendly guidance and long-term commitment.[1][3][4]
Origin Story
Amiti Ventures was founded in 2010 in Tel Aviv (with operations also in Herzliya), Israel, by partners including Modi Rosen and Ben Rabinowitz, who together bring over 30 years of experience in early-stage investing, scaling startups, and driving exits.[1][2][5] The firm emerged from the partners' track record seeding Israel's top tech teams, such as Waze, AppsFlyer, and Aidoc, evolving its focus toward deep tech disruptions in semiconductors, cybersecurity, and AI as Israel's innovation ecosystem matured.[3][4] Key early funds like Amiti Ventures I (2009) and subsequent raises (Amiti Fund II in 2017, Amiti III in 2020) marked its growth, with pivotal moments including partnerships like the 2023 collaboration with AION Labs to invest in AI-driven biotech like DenovAI.[2][3]
Core Differentiators
- Unique Investment Model: Targets seed/A stages with a contrarian, analytical approach to "shifting large markets," investing in bold deep-tech ideas others deem too ambitious, often before category validation.[1][3]
- Network Strength: Leverages U.S.-Israeli ties and a proven history with 36 investments, 8 exits (e.g., Innoviz IPO, Valens NYSE listing), and portfolio stars like Vayyar, Cycognito, and NextSilicon.[2][3][4]
- Track Record: Seeded market leaders including Waze and AppsFlyer; recent bets like Flow Security, Dataloop, and DenovAI highlight focus on AI, cyber, and biotech.[3][4]
- Operating Support: Provides tailored involvement—strategic advice, team focusing for product-market fit, scaling expertise, and critical decision-making aid—while remaining founder-friendly.[1][3]
Role in the Broader Tech Landscape
Amiti rides the wave of Israel's "Startup Nation" dominance in deep tech, capitalizing on trends like AI, autonomous vehicles (Innoviz), semiconductors (NextSilicon), and cybersecurity amid global chip shortages and data explosion.[2][3][4] Timing is ideal post-2020s funding boom, with Amiti's early bets aligning with market forces such as U.S.-Israel tech alliances, rising AI/biotech demand (e.g., AION Labs partnership), and supply chain reshoring favoring Israeli innovation.[2][3] By nurturing outliers to IPOs and acquisitions, Amiti amplifies Israel's ecosystem influence, exporting talent and tech to global giants and shaping categories like LiDAR (Innoviz) and edge AI.[3][4]
Quick Take & Future Outlook
Amiti is primed to lead Israel's next deep-tech surge, with Amiti IV fueling bets in AI, quantum, and biotech amid maturing exits and hyperscaler demand.[2][3] Trends like computational drug discovery (DenovAI) and secure data flows (Flow Security) will propel its portfolio, potentially yielding more unicorns as geopolitical stability boosts Israeli outbound scaling.[2][3] Its influence may evolve toward global venture studios and U.S. expansion, solidifying its role as the go-to backer for tomorrow's industry creators—empowering the outliers who redefine tech frontiers.[1][3]
